Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (471-480 of 651) with videos related to

Pageof 66
Sort By:
Annals of Hematology|January 21, 2026
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
Blood|November 10, 2016
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminusMonica Cusan, Naidu M Vegi, Medhanie A Mulaw, et al.
BMJ Open Respiratory Research|October 6, 2020
Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive <i>CFTR</i> genetics and sweat testRebecca Minso, Angela Schulz, Christian Dopfer, et al.
Annals of Hematology|March 24, 2019
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)Torsten Kessler, Steffen Koschmieder, Christoph Schliemann, et al.
Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.
International Journal of Cancer|July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trialTobias Roider, Xi Wang, Katrin Hüttl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative GroupThomas Büchner, Wolfgang E Berdel, Claudia Haferlach, et al.
Oncogene|May 7, 2021
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemiaMaria V Yusenko, Amke Trentmann, Debora A Casolari, et al.
International Journal of Cancer|February 24, 2015
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancerEtmar Bulk, Anne-Sophie Ay, Mehdi Hammadi, et al.
Haematologica|April 5, 2011
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trialMatthias Stelljes, Dietrich W Beelen, Jan Braess, et al.
Pageof 66

Showing results (471-480 of 651) with videos related to

Sort By:
Pageof 66
Annals of Hematology|January 21, 2026
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
Blood|November 10, 2016
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminusMonica Cusan, Naidu M Vegi, Medhanie A Mulaw, et al.
BMJ Open Respiratory Research|October 6, 2020
Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive <i>CFTR</i> genetics and sweat testRebecca Minso, Angela Schulz, Christian Dopfer, et al.
Annals of Hematology|March 24, 2019
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)Torsten Kessler, Steffen Koschmieder, Christoph Schliemann, et al.
Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.
International Journal of Cancer|July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trialTobias Roider, Xi Wang, Katrin Hüttl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative GroupThomas Büchner, Wolfgang E Berdel, Claudia Haferlach, et al.
Oncogene|May 7, 2021
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemiaMaria V Yusenko, Amke Trentmann, Debora A Casolari, et al.
International Journal of Cancer|February 24, 2015
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancerEtmar Bulk, Anne-Sophie Ay, Mehdi Hammadi, et al.
Haematologica|April 5, 2011
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trialMatthias Stelljes, Dietrich W Beelen, Jan Braess, et al.
Pageof 66